Global POC Blood Glucose Monitoring Devices Market 2018-2022

  • ID: 4463465
  • Report
  • Region: Global
  • 130 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 7

FEATURED COMPANIES

  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann -La Roche
  • Johnson & Johnson
  • MORE
About POC Blood Glucose Monitoring Devices

POC blood glucose monitoring devices are portable, near-patient devices that allow the immediate detection of glucose levels in a patient and facilitate rapid treatment solutions if the need arises. These devices consist of minimum operator interaction and are non-invasive in nature with efficient data management and connectivity tools.

The analysts forecast the global POC blood glucose monitoring devices market to grow at a USD 2,036.4 million during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global POC blood glucose monitoring devices market for 2018-2022. To calculate the market size, the report considers the revenue generated from the POC blood glucose monitoring devices.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global POC Blood Glucose Monitoring Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson
Market drivers
  • Public and private initiatives to reduce diabetic cases
  • For a full, detailed list, view the full report
Market challenges
  • High cost associated with diabetes management
  • For a full, detailed list, view the full report
Market trends
  • Paradigm shift towards non-invasive products
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 7

FEATURED COMPANIES

  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann -La Roche
  • Johnson & Johnson
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Consumables
  • Instruments
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER
  • Segmentation by end-user
  • Hospitals and clinics
  • Clinical diagnostic laboratories
  • Home care settings
PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • POC blood glucose monitoring devices market in Americas
  • POC blood glucose monitoring devices market in EMEA
  • POC blood glucose monitoring devices market in APAC
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS
  • Paradigm shift towards non-invasive products
  • Increase in online product sales
  • Product bundling
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive landscape
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Other prominent vendors
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global IVD market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global - Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global POC blood glucose monitoring devices by Product - Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Product 1 - Year over year growth 2018-2022 (%)
Exhibit 22: Product 2 - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Product 2 - Year over year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global POC blood glucose monitoring devices market by end-user - Market share 2027 (%)
Exhibit 27: Global POC blood glucose monitoring devices - Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: POC blood glucose monitoring devices market in the Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 30: POC blood glucose monitoring devices market in the Americas - Year over year growth 2018-2022 (%)
Exhibit 31: Top 3 countries in Americas
Exhibit 32: POC blood glucose monitoring devices market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: POC blood glucose monitoring devices market in EMEA - Year over year growth 2018-2022 (%)
Exhibit 34: Top 3 countries in EMEA
Exhibit 35: POC blood glucose monitoring devices market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: POC blood glucose monitoring devices market in APAC - Year over year growth 2018-2022 (%)
Exhibit 37: Top 3 countries in APAC
Exhibit 38: Global POC blood glucose monitoring devices market opportunity
Exhibit 39: Various programs to reduce cost burden for diabetics
Exhibit 40: Vendor landscape
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Landscape disruption
Exhibit 44: Competitive structure analysis of global POC blood glucose monitoring devices market 2016
Exhibit 45: Vendors covered
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Market positioning of vendors
Exhibit 51: Abbott overview
Exhibit 52: Abbott - Business segments
Exhibit 53: Abbott - Organizational developments
Exhibit 54: Abbott - Geographic focus
Exhibit 55: Abbott- Segment focus
Exhibit 56: Abbott - Key offerings
Exhibit 57: Abbott - Key customers
Exhibit 58: ARKRAY overview
Exhibit 59: ARKRAY - Business segments
Exhibit 60: ARKRAY - Organizational developments
Exhibit 61: ARKRAY- Geographic focus
Exhibit 62: ARKRAY- Segment focus
Exhibit 63: ARKRAY - Key offerings
Exhibit 64: ARKRAY- Key customers
Exhibit 65: Ascensia Diabetes Care overview
Exhibit 66: Ascensia Diabetes Care- Business segments
Exhibit 67: Ascensia Diabetes Care - Organizational developments
Exhibit 68: Ascensia Diabetes Care - Geographic focus
Exhibit 69: Ascensia Diabetes Care - Segment focus
Exhibit 70: Ascensia Diabetes Care - Key offerings
Exhibit 71: Ascensia Diabetes Care - Key customers
Exhibit 72: Danaher overview
Exhibit 73: Danaher - Business segments
Exhibit 74: Danaher - Organizational developments
Exhibit 75: Danaher - Geographic focus
Exhibit 76: Danaher - Segment focus
Exhibit 77: Danaher- Key offerings
Exhibit 78: Danaher- Key customers
Exhibit 79: F. Hoffmann-La Roche overview
Exhibit 80: F. Hoffmann-La Roche - Business segments
Exhibit 81: F. Hoffmann-La Roche- Organizational developments
Exhibit 82: F. Hoffmann-La Roche - Geographic focus
Exhibit 83: F. Hoffmann-La Roche - Segment focus
Exhibit 84: F. Hoffmann-La Roche - Key offerings
Exhibit 85: F. Hoffmann-La Roche - Key customers
Exhibit 86: Vendor overview
Exhibit 87: Vendor 1 - Business segments
Exhibit 88: Vendor 1 - Organizational developments
Exhibit 89: Vendor 1 - Geographic focus
Exhibit 90: Vendor 1 - Segment focus
Exhibit 91: Vendor 1 - Key offerings
Exhibit 92: Vendor 1 - Key customers
Note: Product cover images may vary from those shown
3 of 7

Loading
LOADING...

4 of 7

FEATURED COMPANIES

  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann -La Roche
  • Johnson & Johnson
  • MORE
New Report Released: - Global POC Blood Glucose Monitoring Devices Market 2018-2022

The author of the report recognizes the following companies as the key players in the global POC blood glucose monitoring devices market: Abbott, ARKRAY, Ascensia Diabetes Care, Danaher, F. Hoffmann -La Roche, and Johnson & Johnson

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Paradigm shift towards non-invasive products. The non-invasive POC blood glucose monitoring devices are hand-held devices that offer numerous benefits over finger prick glucose test such. Non-invasive POC blood glucose monitoring helps to avoid finger prick, which is a convenient, easy to read large number display. Moreover, it can track patient compliance, and multiple test can help to provide adequate therapeutic decisions by healthcare providers. ”

According to the report, one of the major drivers for this market is Public and private initiatives to reduce diabetic cases. There is an increasing case of lifestyle diseases such as diabetes, which affects individual's ability to turn food into energy. Diabetes is of three types: type 1, type 2, and gestational diabetes (diabetes during pregnancy). According to CDC, as on 2017, approximately 30.3 million individuals residing in the US have diabetes, and more than 95% of these diabetic patients have type 2 diabetes. Type 2 diabetes is caused owing to several factors such as heredity, obesity, unhealthy diet, and sedentary lifestyle.

Further, the report states that one of the major factors hindering the growth of this market is High cost associated with diabetes management. Majority of POC blood glucose monitoring devices manufactured by various global and local players are cost-efficient. However, the cost associated with diabetes management in high, leading to out of -pocket expenditure for consumables used in POC blood glucose monitoring devices. Consumables such as blood glucose test strips, reagents, and cassettes are expensive and are required for daily usage. An invasive device such as lancet is bought separately along with the POC blood monitoring devices, leading to additional cost incurred.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 7
  • Abbott
  • ARKRAY
  • Ascensia Diabetes Care
  • Danaher
  • F. Hoffmann -La Roche
  • Johnson & Johnson
Note: Product cover images may vary from those shown
6 of 7
The methodology is available for download below.
7 of 7
Note: Product cover images may vary from those shown
Adroll
adroll